COM:X4PHARMA
X4 Pharmaceuticals
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
x4pharma.comcrunchbase
x4-pharmaceuticalslinkedin
x4-pharmaceuticalsipo date
Nov 16, 2017
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase III clinical trial for the treat...Show More